Seroprevalence of coxsackievirus A21 neutralizing antibodies in Yamagata, Japan between 1976 and 2019; coxsackievirus A21 has rarely affected young children.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of medical virology"
DOI: 10.1002/jmv.27470
Abstract: Although coxsackievirus A21 (CV-A21) has been associated with acute respiratory infection (ARI) as well as poliomyelitis-like paralysis, reports of CV-A21 detection have been quite limited both globally and in Japan. CV-A21 strains were isolated from… read more here.
Keywords: neutralizing antibodies; young children; coxsackievirus a21; yamagata japan ... See more keywords
Abstract CT026: Phase 1b study of intratumoral Coxsackievirus A21 (CVA21) and systemicpembrolizumab inadvanced melanoma patients: Interim results of the CAPRA clinical trial
Sign Up to like & getrecommendations! Published in 2017 at "Cancer Research"
DOI: 10.1158/1538-7445.am2017-ct026
Abstract: Background: Coxsackievirus A21 (CVA21) is a novel bio-selected oncolytic, immunotherapeutic agent. Intratumoral (i.t.) CVA21 injection can induce selective tumor-cell infection, immune-cell infiltration, IFN-γ response gene up-regulation, increased PD-L1 expression, tumor cell lysis and systemic anti-tumor… read more here.
Keywords: clinical trial; cva21; study; coxsackievirus a21 ... See more keywords